Regarding the classification of adverse drug reactions (ADRs) by Rawlins and Thompson, all of the following statements are TRUE EXCEPT:

Explanation

## Classification of Adverse Drug Reactions (Rawlins & Thompson) ### Type A (Augmented) Reactions **Key Point:** Dose-dependent, predictable, exaggerated pharmacological effects. Account for ~80% of all ADRs. - Examples: Bleeding with warfarin overdose, hypoglycemia with excess insulin - Occur in anyone if dose is high enough - Reversible upon dose reduction or drug withdrawal ### Type B (Bizarre/Idiosyncratic) Reactions **Key Point:** Unpredictable, dose-independent, occur in genetically susceptible individuals. - Not related to known pharmacology of the drug - Examples: Stevens-Johnson syndrome (SJS), anaphylaxis, drug-induced lupus - Account for ~15% of ADRs - Often immune-mediated but NOT always ### Type C (Chronic) Reactions **Key Point:** Time-dependent, occur after prolonged exposure or drug withdrawal. - Examples: Benzodiazepine dependence, corticosteroid-induced osteoporosis, tardive dyskinesia - Cumulative toxicity over months/years ### Type D (Delayed) Reactions **Key Point:** Occur long after drug exposure ends; typically teratogenic or carcinogenic. - Examples: Thalidomide-induced limb defects (fetal), DES-induced vaginal adenocarcinoma (decades later) - Account for ~2–3% of ADRs ### Why Option 4 is INCORRECT | Reaction Type | % of All ADRs | Immune-Mediated? | |---|---|---| | Type A (Augmented) | ~80% | No — pharmacological | | Type B (Bizarre) | ~15% | Often, but not always | | Type C (Chronic) | ~3% | Variable | | Type D (Delayed) | ~2–3% | Often teratogenic/carcinogenic | **High-Yield:** Type B reactions (idiosyncratic, unpredictable) are the ones classically associated with immune mechanisms (hypersensitivity, anaphylaxis, drug-induced autoimmunity). However, Type B reactions account for only ~15% of all ADRs, NOT the majority. Type A reactions (dose-dependent, pharmacological) account for the majority (~80%). **Clinical Pearl:** The question stem says Type D reactions are "immune-mediated and account for the majority" — this is doubly wrong. Type D reactions are delayed (teratogenic/carcinogenic), not primarily immune-mediated, and they account for only 2–3% of ADRs. [cite:KD Tripathi 8e Ch 10]